As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Wolverine Trading LLC, Squarepoint Ops LLC, Royal Bank of Canada, Man Group plc, Nomura Holdings Inc., Maven Securities LTD, Millennium Management LLC, J. Goldman & Co LP, Jefferies Financial Group Inc., Group One Trading LLC, Focus Partners Wealth, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cresset Asset Management LLC, Cubist Systematic Strategies LLC, Bosun Asset Management LLC, Cantor Fitzgerald L. P., Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, ADAPT Investment Managers SA, Jane Street Group LLC, Lido Advisors LLC, Parallax Volatility Advisers L.P., Diadema Partners LP, Susquehanna International Group LLP, HAP Trading LLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Capula Management Ltd, Bank of Nova Scotia, Wells Fargo & Company MN, ExodusPoint Capital Management LP, JPMorgan Chase & Co., LPL Financial LLC, Simplex Trading LLC, Twin Tree Management LP, Delta Accumulation LLC, Marathon Trading Investment Management LLC, Allianz Asset Management GmbH, Wolverine Asset Management LLC, Gladius Capital Management LP, Genus Capital Management Inc., IMC Chicago LLC, Portman Square Capital LLP, NorthCrest Asset Manangement LLC, Wealth Enhancement Advisory Services LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.